2 spectra of Δ 8,11,14 20:3-AMPP obtained by a LIT instrument applying low-energy CID (optimized to 65% normalized CE) (c), and HCD (optimized to 50% normalized CE) (d). Panel f shows the low energy CID (60% normalized CE) LIT MS 2 spectrum of Δ 14,17,20,23,26,29 32:6-AMPP, and the spectrum is similar to that acquired by LIFT TOF-TOF (panel c)^does not match the mass spectra data presented. The spectrum in panel e is MALDI LIFT TOF-TOF spectrum of Δ 14,17,20,23,26,29 20:3-AMPP obtained by a LIT instrument applying low-energy CID (optimized to 65% normalized CE) (c), and HCD (optimized to 50% normalized CE) (d), respectively; and should be presented as panel d and panel e, respectively. The legend (Fig. 3) B(b) 14-methyl-hexadecanoic acid-AMPP (anteiso), and (c) 15-methylhexadecanoic acid-AMPP (iso)^should be B(b) 15-methylhexadecanoic acid-AMPP (iso) and (c) 14-methylhexadecanoic acid-AMPP (anteiso)^. We apologize for the errors.
20:3-AMPP obtained by a LIT instrument applying low-energy CID (optimized to 65% normalized CE) (c), and HCD (optimized to 50% normalized CE) (d). Panel f shows the low energy CID (60% normalized CE) LIT MS 2 spectrum of Δ 14, 17, 20, 23, 26, 29 32:6-AMPP, and the spectrum is similar to that acquired by LIFT TOF-TOF (panel c)^does not match the mass spectra data presented. The spectrum in panel e is MALDI LIFT TOF-TOF spectrum of Δ 14, 17, 20, 23, 26, 29 20:3-AMPP obtained by a LIT instrument applying low-energy CID (optimized to 65% normalized CE) (c), and HCD (optimized to 50% normalized CE) (d), respectively; and should be presented as panel d and panel e, respectively. The legend (Fig. 3) B(b) 14-methyl-hexadecanoic acid-AMPP (anteiso), and (c) 15-methylhexadecanoic acid-AMPP (iso)^should be B(b) 15-methylhexadecanoic acid-AMPP (iso) and (c) 14-methylhexadecanoic acid-AMPP (anteiso)^. We apologize for the errors.
